CD47 Selection for Mesencephalic Dopaminergic Progenitor Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating mesencephalic dopaminergic progenitor cells from pluripotent and multipotent stem cells are not reproducible and are largely manual, leading to user-dependent variations and inefficiencies, which hinders their clinical application, especially in treating Parkinson's disease.
Innovation Solution
The use of CD47 as a cell surface marker for isolating mesencephalic dopaminergic progenitor cells allows for standardized and automated generation of a diverse cell composition resembling the ventral mesencephalon of human embryos, enabling reproducible production under GMP-like conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If manual methods are used for generating mesencephalic dopaminergic progenitor cells, then flexibility in protocol adjustment is maintained, but reproducibility and manufacturing precision deteriorate due to user-dependent variations
Solution Approach 1:
The patent applies parameter changes by establishing specific, standardized culture conditions including defined media compositions, precise incubation temperatures, controlled oxygen levels, and standardized passage timing. These parameter standardizations eliminate user-dependent variations while maintaining protocol effectiveness, directly resolving the contradiction between reproducibility and automation complexity
Solution Approach 2:
The patent employs copying by creating standardized, replicable protocols that can be consistently reproduced across different laboratories and operators. The detailed standardization of cell passage procedures, media preparation, and culture conditions creates a master protocol that can be copied and implemented uniformly, improving manufacturing precision without requiring complex automated systems
2Productivity
If complex manual protocols with frequent media changes and cell handling are used, then cell differentiation can be controlled, but productivity and time efficiency deteriorate
Solution Approach 1:
The patent applies preliminary action by pre-preparing and optimizing culture media formulations before cell culture initiation. The standardized media compositions and pre-established culture protocols eliminate the need for frequent adjustments and media changes during the differentiation process, thereby improving productivity without extending the overall process duration
Solution Approach 2:
The patent implements continuity of useful action by establishing stable, long-term culture conditions that maintain cell differentiation without requiring frequent interruptions for media changes or protocol adjustments. The optimized culture system allows continuous cultivation and differentiation, significantly improving generation efficiency while reducing the time lost to manual interventions
3Reliability
If heterogeneous cell populations are used without selection, then cell diversity is maintained, but purity and clinical applicability deteriorate due to contaminating cell types
Solution Approach 1:
The patent applies the taking out principle by selectively isolating and enriching mesencephalic dopaminergic progenitor cells from heterogeneous cell populations through marker-based selection. This extraction of target cells from contaminating cell types improves purity and clinical applicability while maintaining a standardized, manageable isolation process that does not require overly complex manufacturing procedures
Solution Approach 2:
The patent employs an intermediary approach by using cell surface markers and selection reagents as mediators to separate desired dopaminergic progenitor cells from contaminating cell types. These intermediary tools enable precise cell population selection without requiring complex manual sorting procedures, thereby improving reliability while keeping the manufacturing process straightforward
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method results in a more complex and diverse cell composition that is clinically applicable, improving the regeneration of lost tissue in patients with Parkinson's disease by providing a standardized and automated process for cell therapy.
Implementation Method 1
contacting the single cell suspension with an antigen binding molecule specific for the CD47 antigen, thereby positively selecting the mesencephalic dopaminergic progenitor cells
Data Source
AI summary
The present invention provides a method for generation of a cell composition of mesencephalic dopaminergic progenitor cells from a starting cell composition comprising pluripotent and/or multipotent stem cells, the method comprising the steps of a) differentiating said pluripotent and/or multipotent stem cells into mesencephalic dopaminergic progenitor cells, thereby generating a cell population comprising mesencephalic dopaminergic progenitor cells and other cells, b) dissociating the differentiated cells of step a) into a single cell suspension, and c) enriching said mesencephalic dopaminergic progenitor cells by using an antigen binding molecule specific for the CD47 antigen for positive selection of said mesencephalic dopaminergic progenitor cells in said single cell suspension. Said method may be performed in a closed cell sample processing system and may be performed in an automated manner.